200
Views
17
CrossRef citations to date
0
Altmetric
Original Articles

Aortic remodelling following the treatment and regression of hypertensive left ventricular hypertrophy: a cardiovascular magnetic resonance study

, , , , , & show all
Pages 308-316 | Received 13 Jun 2014, Accepted 15 Aug 2014, Published online: 01 Oct 2014

References

  • Lehmann ED. Clinical value of aortic pulse-wave velocity measurement. Lancet 1999;354:528–9
  • Hirai T, Sasayama S, Kawasaki T, Yagi S. Stiffness of systemic arteries in patients with myocardial infarction. A noninvasive method to predict severity of coronary atherosclerosis. Circulation 1989;80:78–86
  • Willum-Hansen T, Staessen JA, Torp-Pedersen C, et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 2006;113:664–70
  • Mattace-Raso FU, van der Cammen TJ, Hofman A, et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation 2006;113:657–63
  • Laurent S, Katsahian S, Fassot C, et al. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke 2003;34:1203–6
  • Boutouyrie P, Tropeano AI, Asmar R, et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 2002;39:10–5
  • Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001;37:1236–41
  • Sutton-Tyrrell K, Najjar SS, Boudreau RM, et al. Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation 2005;111:3384–90
  • Cruickshank K, Riste L, Anderson SG, et al. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation 2002;106:2085–90
  • Blacher J, Guerin AP, Pannier B, et al. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999;99:2434–9
  • Blacher J, Pannier B, Guerin AP, et al. Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension 1998;32:570–4
  • Metafratzi ZM, Efremidis SC, Skopelitou AS, De Roos A. The clinical significance of aortic compliance and its assessment with magnetic resonance imaging. J Cardiovasc Magn Reson 2002;4:481–91
  • Nelson AJ, Worthley SG, Cameron JD, et al. Cardiovascular magnetic resonance-derived aortic distensibility: validation and observed regional differences in the elderly. J Hypertens 2009;27:535–42
  • Greenwood JP, Scott EM, Stoker JB, Mary DA. Hypertensive left ventricular hypertrophy: relation to peripheral sympathetic drive. J Am Coll Cardiol 2001;38:1711–17
  • Devereux RB, Wachtell K, Gerdts E, et al. Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA 2004;292:2350–6
  • Yurenev AP, Dyakonova HG, Novikov ID, et al. Management of essential hypertension in patients with different degrees of left ventricular hypertrophy. Multicenter trial. Am J Hypertens 1992;5:182S–9
  • Muiesan ML, Salvetti M, Rizzoni D, et al. Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment. J Hypertens 1995;13:1091–5
  • Burns J, Ball SG, Worthy G, et al. Hypertensive left ventricular hypertrophy: a mechanistic approach to optimizing regression assessed by cardiovascular magnetic resonance. J Hypertens 2012;30:2039–46
  • Dernellis J, Panaretou M. Aortic stiffness is an independent predictor of progression to hypertension in nonhypertensive subjects. Hypertension 2005;45:426–31
  • Asmar RG, Pannier B, Santoni JP, et al. Reversion of cardiac hypertrophy and reduced arterial compliance after converting enzyme inhibition in essential hypertension. Circulation 1988;78:941–50
  • De Luca N, Ricciardelli B, Rosiello G, et al. Stable improvement in large artery compliance after long-term antihypertensive treatment with enalapril. Am J Hypertens 1988;1:181–3
  • De Luca N, Rosiello G, Lamenza F, et al. Reversal of cardiac and large artery structural abnormalities induced by long-term antihypertensive treatment with trandolapril. Am J Cardiol 1992;70:52D–9
  • Karalliedde J, Smith A, DeAngelis L, et al. Valsartan improves arterial stiffness in type 2 diabetes independently of blood pressure lowering. Hypertension 2008;51:1617–23
  • Richer C, Mulder P, Fornes P, et al. Hemodynamic and morphological effects of quinapril during genetic hypertension development. J Cardiovasc Pharmacol 1991;18:631–42
  • Clozel M, Kuhn H, Hefti F, Baumgartner HR. Endothelial dysfunction and subendothelial monocyte macrophages in hypertension. Effect of angiotensin converting enzyme inhibition. Hypertension 1991;18:132–41
  • Stewart AD, Jiang B, Millasseau SC, et al. Acute reduction of blood pressure by nitroglycerin does not normalize large artery stiffness in essential hypertension. Hypertension 2006;48:404–10
  • Alfakih K, Plein S, Thiele H, et al. Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging sequences. J Magn Reson Imaging 2003;17:323–9
  • Burns J, Sivananthan MU, Ball SG, et al. Relationship between central sympathetic drive and magnetic resonance imaging-determined left ventricular mass in essential hypertension. Circulation 2007;115:1999–2005
  • Lorenz CH, Walker ES, Morgan VL, et al. Normal human right and left ventricular mass, systolic function, and gender differences by cine magnetic resonance imaging. J Cardiovasc Magn Reson 1999;1:7–21
  • Oliver JJ, Webb DJ. Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol 2003;23:554–66
  • Lip GY. Regression of left ventricular hypertrophy and improved prognosis: some hope now or hype? Circulation 2001;104:1582–4
  • Sutton-Tyrrell K, Newman A, Simonsick EM, et al. Aortic stiffness is associated with visceral adiposity in older adults enrolled in the study of health, aging, and body composition. Hypertension 2001;38:429–33
  • Mitchell GF, Guo CY, Benjamin EJ, et al. Cross-sectional correlates of increased aortic stiffness in the community: the Framingham Heart Study. Circulation 2007;115:2628–36
  • Laurent S, Cockcroft J, Van Bortel L, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006;27:2588–605
  • Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007;28:1462–536
  • Dogui A, Kachenoura N, Frouin F, et al. Consistency of aortic distensibility and pulse wave velocity estimates with respect to the Bramwell–Hill theoretical model: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 2011;13:11
  • Benetos A. Pulse pressure and cardiovascular risk. J Hypertens Suppl 1999;17:S21–4
  • Nichols WW, Edwards DG. Arterial elastance and wave reflection augmentation of systolic blood pressure: deleterious effects and implications for therapy. J Cardiovasc Pharmacol Ther 2001;6:5–21
  • Nussbacher A, Gerstenblith G, O’Connor FC, et al. Hemodynamic effects of unloading the old heart. Am J Physiol 1999;277:H1863–71
  • Urschel CW, Covell JW, Sonnenblick EH, et al. Effects of decreased aortic compliance on performance of the left ventricle. Am J Physiol 1968;214:298–304
  • Levy BI, Curmi P, Poitevin P, Safar ME. Modifications of the arterial mechanical properties of normotensive and hypertensive rats without arterial pressure changes. J Cardiovasc Pharmacol 1989;14:253–9
  • Levy BI, Poitevin P, Safar ME. Effects of indapamide on the mechanical properties of the arterial wall in deoxycorticosterone acetate-salt hypertensive rats. Am J Cardiol 1990;65:28H–32
  • Breithaupt-Grogler K, Leschinger M, Belz GG, et al. Influence of antihypertensive therapy with cilazapril and hydrochlorothiazide on the stiffness of the aorta. Cardiovasc Drugs Ther 1996;10:49–57
  • Weir MR. Targeting mechanisms of hypertensive vascular disease with dual calcium channel and renin–angiotensin system blockade. J Hum Hypertens 2007;21:770–9
  • Benetos A, Vasmant D, Thiery P, Safar M. Effects of ramipril on arterial hemodynamics. J Cardiovasc Pharmacol 1991;18:S153–6
  • Scalbert E, Levy B, Desche P, et al. Vascular effects of perindopril: from experimental to clinical investigation. J Cardiovasc Pharmacol 1991;18:S25–32
  • Barenbrock M, Spieker C, Hoeks AP, et al. Effect of lisinopril and metoprolol on arterial distensibility. Hypertension 1994;23:I161–3
  • Wang DH, Prewitt RL. Captopril reduces aortic and microvascular growth in hypertensive and normotensive rats. Hypertension 1990;15:68–77
  • Levy BI, Michel JB, Salzmann JL, et al. Arterial effects of angiotensin converting enzyme inhibition in renovascular and spontaneously hypertensive rats. J Hypertens Suppl 1988;6:S23–5
  • Tornig J, Amann K, Ritz E, et al. Arteriolar wall thickening, capillary rarefaction and interstitial fibrosis in the heart of rats with renal failure: the effects of ramipril, nifedipine and moxonidine. J Am Soc Nephrol 1996;7:667–75
  • Dorresteijn JA, Schrover IM, Visseren FL, et al. Differential effects of renin–angiotensin–aldosterone system inhibition, sympathoinhibition and diuretic therapy on endothelial function and blood pressure in obesity-related hypertension: a double-blind, placebo-controlled cross-over trial. J Hypertens 2013;31:393–403
  • Shirai K, Utino J, Saiki A, et al. Evaluation of blood pressure control using a new arterial stiffness parameter, cardio-ankle vascular index (CAVI). Curr Hypertens Rev 2013;9:66–75
  • Komai N, Ohishi M, Moriguchi A, et al. Low-dose doxazosin improved aortic stiffness and endothelial dysfunction as measured by noninvasive evaluation. Hypertens Res 2002;25:5–10
  • de la Chica-Rodriguez S, Cortes-Denia P, Ramirez-Exposito MJ, Martinez-Martos JM. Effects of alpha1-adrenergic receptor blockade by doxazosin on renin–angiotensin system-regulating aminopeptidase and vasopressin-degrading activities in male and female rat thalamus. Horm Metab Res 2007;39:813–17
  • Honda T, Yano K, Matsuoka H, et al. Evaluation of aortic distensibility in patients with essential hypertension by using cine magnetic resonance imaging. Angiology 1994;45:207–12
  • Guerin AP, Blacher J, Pannier B, et al. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 2001;103:987–92

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.